These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30259253)

  • 21. Functional evaluation of the heart with magnetic resonance imaging.
    Higgins CB; Holt W; Pflugfelder P; Sechtem U
    Magn Reson Med; 1988 Feb; 6(2):121-39. PubMed ID: 3367771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated MR imaging approach to valvular heart disease.
    Wyttenbach R; Bremerich J; Saeed M; Higgins CB
    Cardiol Clin; 1998 May; 16(2):277-94. PubMed ID: 9627761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques.
    Kon MW; Myerson SG; Moat NE; Pennell DJ
    J Heart Valve Dis; 2004 Jul; 13(4):600-7. PubMed ID: 15311866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular magnetic resonance in the evaluation of heart valve disease.
    Gulsin GS; Singh A; McCann GP
    BMC Med Imaging; 2017 Dec; 17(1):67. PubMed ID: 29284450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography.
    Caruthers SD; Lin SJ; Brown P; Watkins MP; Williams TA; Lehr KA; Wickline SA
    Circulation; 2003 Nov; 108(18):2236-43. PubMed ID: 14568899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement.
    Musa TA; Plein S; Greenwood JP
    Quant Imaging Med Surg; 2016 Jun; 6(3):259-73. PubMed ID: 27429910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review.
    Gorecka M; Bissell MM; Higgins DM; Garg P; Plein S; Greenwood JP
    J Cardiovasc Magn Reson; 2022 Aug; 24(1):49. PubMed ID: 35989320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart valve disease: investigation by cardiovascular magnetic resonance.
    Myerson SG
    J Cardiovasc Magn Reson; 2012 Jan; 14(1):7. PubMed ID: 22260363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow assessment through four heart valves simultaneously using 3-dimensional 3-directional velocity-encoded magnetic resonance imaging with retrospective valve tracking in healthy volunteers and patients with valvular regurgitation.
    Roes SD; Hammer S; van der Geest RJ; Marsan NA; Bax JJ; Lamb HJ; Reiber JH; de Roos A; Westenberg JJ
    Invest Radiol; 2009 Oct; 44(10):669-75. PubMed ID: 19724233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of echocardiography for catheter-based management of valvular heart disease.
    Shiota T
    J Cardiol; 2017 Jan; 69(1):66-73. PubMed ID: 27863908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of Tricuspid Insufficiency and the Function of Right Ventricle Using Cardiac Magnetic Resonance Imaging Combined with Echocardiography].
    Chen H; Zhao Y; Yu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):940-4. PubMed ID: 26710474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cardiac valvular disease with MR imaging: qualitative and quantitative techniques.
    Glockner JF; Johnston DL; McGee KP
    Radiographics; 2003; 23(1):e9. PubMed ID: 12886890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in quantification of mitral valve regurgitation: role of cardiac magnetic resonance imaging.
    Connelly KA; Ho EC; Leong-Poi H
    Curr Opin Cardiol; 2017 Mar; 32(2):152-160. PubMed ID: 27861188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of valvular disease by cardiac computed tomography assessment.
    Buttan AK; Yang EH; Budoff MJ; Vorobiof G
    J Cardiovasc Comput Tomogr; 2012; 6(6):381-92. PubMed ID: 23217461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of mitral regurgitation by 3-dimensional proximal flow convergence using magnetic resonance imaging: comparison with echo-Doppler.
    Gorodisky L; Agmon Y; Porat M; Abadi S; Lessick J
    Int J Cardiovasc Imaging; 2018 May; 34(5):793-802. PubMed ID: 29260346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inline directionally independent peak velocity evaluation reduces error in peak antegrade velocity estimation in patients referred for cardiac valvular assessment.
    Hodnett PA; Glielmi CB; Davarpanah AH; Scanlon TG; Ward E; Collins JD; Weale PJ; Carr JC
    AJR Am J Roentgenol; 2012 Feb; 198(2):344-50. PubMed ID: 22268176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valvular and hemodynamic assessment with CMR.
    Myerson SG
    Heart Fail Clin; 2009 Jul; 5(3):389-400, vi-vii. PubMed ID: 19564015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of valvular heart disease with cine gradient echo magnetic resonance imaging.
    Higgins CB; Wagner S; Kondo C; Suzuki J; Caputo GR
    Circulation; 1991 Sep; 84(3 Suppl):I198-207. PubMed ID: 1884487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using cardiac magnetic resonance imaging to evaluate cardiac function and predict outcomes in patients with valvular heart disease.
    Emerson DA; Amdur RL; Morrissette JR; Mordini FE; Nagy CD; Greenberg MD; Trachiotis GD
    Innovations (Phila); 2015; 10(1):63-7. PubMed ID: 25628254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of global left ventricular function with dual-source computed tomography in patients with valvular heart disease.
    Bak SH; Ko SM; Jeon HJ; Yang HS; Hwang HK; Song MG
    Acta Radiol; 2012 Apr; 53(3):270-7. PubMed ID: 22319133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.